$336 Million is the total value of Integral Health Asset Management, LLC's 57 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -50,000 | -100.0% | -0.22% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.26% | – |
| GMAB | Exit | GENMAB A/Ssponsored ads | $0 | – | -30,000 | -100.0% | -0.34% | – |
| Exit | INOVIO PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -0.36% | – | |
| Exit | GOSSAMER BIO INCcall | $0 | – | -100,000 | -100.0% | -0.38% | – | |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -0.44% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -125,000 | -100.0% | -0.54% | – |
| CHWY | Exit | CHEWY INCcl a | $0 | – | -35,000 | -100.0% | -0.59% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -40,000 | -100.0% | -0.61% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -30,000 | -100.0% | -0.71% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -30,000 | -100.0% | -0.73% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -6,000 | -100.0% | -0.76% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -200,000 | -100.0% | -0.76% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -90,000 | -100.0% | -0.83% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -175,000 | -100.0% | -0.83% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -15,000 | -100.0% | -0.84% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -12,000 | -100.0% | -0.87% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -35,000 | -100.0% | -0.92% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -50,000 | -100.0% | -0.92% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -30,000 | -100.0% | -0.98% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -40,000 | -100.0% | -0.98% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -85,000 | -100.0% | -1.04% | – |
| Exit | MODERNA INCput | $0 | – | -50,000 | -100.0% | -1.08% | – | |
| HOLX | Exit | HOLOGIC INC | $0 | – | -55,000 | -100.0% | -1.12% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -155,000 | -100.0% | -1.25% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -14,500 | -100.0% | -1.27% | – |
| Exit | CYTOKINETICS INCcall | $0 | – | -200,000 | -100.0% | -1.32% | – | |
| PODD | Exit | INSULET CORP | $0 | – | -22,000 | -100.0% | -1.59% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -95,000 | -100.0% | -1.70% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -125,000 | -100.0% | -1.92% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -50,000 | -100.0% | -2.08% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -100,000 | -100.0% | -2.54% | – |
| HUM | Exit | HUMANA INC | $0 | – | -26,000 | -100.0% | -3.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.